Industry Reports

In a bid to offer qualitative radiation therapy and cancer care services, Alliance healthcare services ventures into a stock purchasing agreement with e+CancerCare in order to function…
Read More...

The network of independent health systems based out of Arkansas, Missouri and Texas collaborate with Vizient for comprehensive sourcing, improvement of performance as well as services…
Read More...

Miraca Life sciences declared that it intends to change its name to inform Diagnostics with effect from immediate Avista Capital partners had acquired the company in November. The new…
Read More...

TAI diagnostics that oversees the health of transplanted organs announced the final closing of $10 million Series A preferred equity financing that will aid ongoing research and…
Read More...

A generic pharmaceutical company Leading Pharma, LLC that manufactures and distributes drug chains, wholesalers declared that it became a successful recipient of $ 40 million of growth…
Read More...

In a bid to replace its expired base shelf prospectus and corresponding shelf registration statement on form F-10, Aurinia Pharmaceuticals files new tentative base shelf prospectus …
Read More...

Advanced precision medicine CIRCULOGENE through its molecular genetics testing enters into an international licensing agreement with turkey based CIRCULOGENE Saglik. As per the terms…
Read More...

CanniMed Therapeutics Inc’s wholly owned subsidiary Sub Terra LLC moves to produce and process medical cannabis through its State of Michigan licenses application. The company has…
Read More...

Medicure International has acquired an exclusive license to sell and market PREXXARTAN (valsartan) oral solution in the United States and its territories from Carmel Biosciences, Inc.…
Read More...

Teva Pharmaceutical Industries announced the reintroduction of the generic equivalent to Depo-Provera1 Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP)…
Read More...

Natus Medical Incorporated announced that it has entered into a definitive agreement with Integra LifeSciences Holdings Corporation (NASDAQ:IART) under which Natus will acquire certain…
Read More...

TrialScope has announced the launch its second Clinical Trial Disclosure Maturity Survey for clinical trial sponsors to perform self-assessments of their disclosure practices. The…
Read More...

GSK announced $139 million of new investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for adult patients with…
Read More...

Sorrento Therapeutics announced that it has successfully completed the transaction for acquisition of Virttu Biologics. In consideration for the acquisition, Virttu equity holders…
Read More...

Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg from the United States Food and Drug…
Read More...

XTL Biopharmaceuticals announced that Mr. Alex Rabinovich has been appointed as a member of the Company's board of directors. Mr. Rabinovich is a leading investor in XTL and holds over…
Read More...

Merck announced the divestment of its Biosimilars business to Fresenius. The decision to divest Biosimilars is aligned with Merck’s strategy for its Healthcare business sector to focus…
Read More...

Agios Pharmaceuticals and Aurigene Discovery Technologies announced that they have signed a global license agreement to research, develop and commercialize small molecule inhibitors of…
Read More...

Savara Inc., a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare…
Read More...

Science 37 has raised $29m in Series C funding, led by Glynn Capital Management with participation from GV, to bring clinical trials directly into patients’ homes. The round included…
Read More...